Related Experiment Video
Updated: Jan 26, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
Francesca Rossi1, Chiara Tortora2, Francesca Punzo3,4
1Department of Women, Child, and General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy. francesca.rossi@unicampania.it.
The endocannabinoid/endovanilloid (EC/EV) system influences bone health by modulating osteoclast and osteoblast activity. Targeting EC/EV receptors offers a promising therapeutic strategy for bone diseases like osteoporosis and bone cancer.
Area of Science:
- Bone Biology
- Pharmacology
- Endocrinology
Background:
- Bone homeostasis relies on a balance between osteoclast and osteoblast activity.
- The endocannabinoid/endovanilloid (EC/EV) system, including CB1, CB2, and TRPV1 receptors, modulates bone remodeling.
- Bone diseases like osteoporosis are prevalent globally, stemming from factors including estrogen decline, glucocorticoids, and chemotherapy.
Purpose of the Study:
- To investigate the role of the EC/EV system in bone homeostasis and disease.
- To explore the potential of EC/EV receptors as therapeutic targets for bone disorders.
- To review the dual effects of EC/EV receptor stimulation on bone formation and resorption.
Main Methods:
- Review of existing literature on EC/EV system components (CB1, CB2, TRPV1) and their impact on bone cells.
- Analysis of studies investigating EC/EV system modulation in osteoporosis and bone cancer models.
- Exploration of the therapeutic potential of targeting EC/EV receptors.
Main Results:
- CB1 and TRPV1 receptor stimulation promotes osteoclast activity (bone resorption).
- CB2 receptor stimulation exhibits an anti-osteoclastogenic effect (inhibits bone resorption).
- EC/EV system modulation in bone cancer reduces tumor growth, invasion, and pain in mouse models.
Conclusions:
- EC/EV receptors are critical regulators of bone remodeling and hold therapeutic potential for bone diseases.
- Targeting EC/EV receptors could offer a novel approach for managing osteoporosis and bone cancer.
- Further research into the biochemical mechanisms of the EC/EV system in bone is warranted, with hybrid molecules showing promise.
More Related Videos
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Related Concept Videos
Spongy Bone
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
Compact Bone
Compact bone, also called cortical bone, is the denser, stronger of the two types of bone tissue. It is found under the periosteum and in the diaphyses of long bones, where it provides support and protection. The microscopic structural unit of compact bone is called an osteon, or haversian system. Each osteon is composed of concentric rings of calcified...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Hyoid Bone
Bone Structure
Bone Remodeling